...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of Oncology Practice >Opening the Black Box: The Impact of an Oncology Management Program Consisting of Level I Pathways and an Outbound Nurse Call System
【24h】

Opening the Black Box: The Impact of an Oncology Management Program Consisting of Level I Pathways and an Outbound Nurse Call System

机译：打开黑匣子：由I级路径和出境护士呼叫系统组成的肿瘤学管理程序的影响

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

AbstractImplementation of Innovent positively affected patient care by decreasing ER visits and admissions, in-patient days, and cancer-related use costs and increasing on-pathway adherence. Purpose: The Innovent Oncology Program aims to improve the value of cancer care delivered to patients. McKesson Specialty Health and Texas Oncology (TXO) collaborated with Aetna to launch a pilot program. The study objectives were to evaluate the impact of Innovent on Level I Pathway compliance, implement the Patient Support Services program, and measure the rate and costs associated with chemotherapy-related emergency room (ER) visits and hospital admissions. Patients and Methods: This was a prospective, nonrandomized evaluation of patients enrolled in Innovent from June 1, 2010, through May 31, 2012. Data from the iKnowMed electronic health record, the McKesson Specialty Health financial data warehouse, and Aetna claims data warehouse were analyzed. Results: A total of 221 patients were included and stratified according to disease and age groups; 76% of ordered regimens were on pathway; 24% were off pathway. Pathway adherence improved from TXO baseline adherence of 63%. Of the 221 patients, 81% enrolled in PSS. Within the breast, colorectal, and lung cancer groups, 14% and 24% of patients had an ER visit and in-patient admission (IPA; baseline) versus 10% and 18% in Innovent, respectively; average in-patient days decreased from 2.1 to 1.2 days, respectively. Total savings combined for the program was $506,481. Conclusion: Implementation of Innovent positively affected patient care in several ways: Fewer ER visits and IPAs occurred, in-patient days decreased, cancer-related use costs were reduced, and on-pathway adherence increased.
机译：通过降低ER访问和录取，患者的日期和癌症相关的使用成本以及增加途径依从性，通过降低创新影响患者护理的抽象度。目的：创新肿瘤学计划旨在提高患者癌症护理的价值。 MCKESSON专业健康和德克萨斯舞具（TXO）与AETNA合作推出试点计划。研究目标是评估创新对I级途径合规性的影响，实施患者支持服务计划，并衡量与化疗相关的急诊室（ER）访问和医院录取相关的速率和成本。患者和方法：这是2010年6月1日至2012年5月13日从2012年6月1日起招收创新患者的前瞻性的。来自InkowMed电子健康记录，McKesson专业健康金融数据仓库和Aetna声明数据仓库的数据分析。结果：根据疾病和年龄组共用了221名患者并分层; 76％的有序方案在途中; 24％的途径偏离途径。从TXO基线依从性提高了63％的途径依从性。在221名患者中，81％招收PSS。在乳腺癌，结肠直肠癌和肺癌中，14％和24％的患者分别有一次参观和患者的入学（IPA;基线）分别与创新的10％和18％;平均患者的日子分别从2.1降至1.2天。该计划的总储蓄为506,481美元。结论：以多种方式实施创新影响患者护理：较少的ER访问和IPA，患者的日子减少，癌症相关的使用费率降低，并且途径遵守增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号